These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 47195)

  • 1. Effect of heparin on the neutralization of factor Xa and thrombin by the plasma alpha-2-globulin inhibitor.
    Yin ET
    Thromb Diath Haemorrh; 1975 Feb; 33(1):43-50. PubMed ID: 47195
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition by human thrombomodulin of factor Xa-mediated cleavage of prothrombin.
    Thompson EA; Salem HH
    J Clin Invest; 1986 Jul; 78(1):13-7. PubMed ID: 3013935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identity of plasma-activated factor X inhibitor with antithrombin 3 and heparin cofactor.
    Yin ET; Wessler S; Stoll PJ
    J Biol Chem; 1971 Jun; 246(11):3712-9. PubMed ID: 4102937
    [No Abstract]   [Full Text] [Related]  

  • 4. The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin.
    Ofosu FA; Sie P; Modi GJ; Fernandez F; Buchanan MR; Blajchman MA; Boneu B; Hirsh J
    Biochem J; 1987 Apr; 243(2):579-88. PubMed ID: 2443128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
    Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N
    Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of alpha- and beta- thrombin by antithrombin-III and heparin.
    Machovich R; Blaskó G; Borsodi A
    Thromb Haemost; 1976 Dec; 36(3):503-8. PubMed ID: 65798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of factor Xa from neutralization by the heparin-antithrombin complex.
    Teitel JM; Rosenberg RD
    J Clin Invest; 1983 May; 71(5):1383-91. PubMed ID: 6222069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a new potent heparin. 2nd communication: Chemical analysis of the carbohydrate content and determination of the biological activity of a new potent heparin preparation in vitro, using protamine neutralization and amidolytic methods for factor Xa and thrombin.
    Bhargava AS; Heinick J; Günzel P
    Arzneimittelforschung; 1980; 30(7):1071-4. PubMed ID: 7191289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivity of a hereditary abnormal antithrombin III fraction in the inhibition of thrombin and factor Xa.
    Tran TH; Bondeli C; Marbet GA; Duckert F
    Thromb Haemost; 1980 Oct; 44(2):92-5. PubMed ID: 7455997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of antithrombin III on the activity of the coagulation factors VII, IX and X.
    Osterud B; Miller-Andersson M; Abildgaard U; Prydz H
    Thromb Haemost; 1976 Apr; 35(2):295-304. PubMed ID: 61631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
    Fischer AM; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of activated factor X-induced platelet aggregation: the role of heparin and the plasma inhibitor to activated factor X.
    Yin ET; Giudice LC; Wessler S
    J Lab Clin Med; 1973 Sep; 82(3):390-8. PubMed ID: 4728289
    [No Abstract]   [Full Text] [Related]  

  • 13. Antithrombin 3, antifactor Xa and heparin.
    Biggs R; Denson KW; Akman N; Borrett R; Hadden M
    Br J Haematol; 1970 Sep; 19(3):283-305. PubMed ID: 5529547
    [No Abstract]   [Full Text] [Related]  

  • 14. The conversion of prothrombin to thrombin. V. The activation of prothrombin by factor Xa in the presence of phospholipid.
    Esmon CT; Owen WG; Jackson CM
    J Biol Chem; 1974 Dec; 249(24):7798-807. PubMed ID: 4430675
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII.
    De Cristofaro R; De Filippis V
    Biochem J; 2003 Jul; 373(Pt 2):593-601. PubMed ID: 12689334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of heparin and hirudin on thrombin generation and platelet aggregation after intrinsic activation of platelet rich plasma.
    Gallistl S; Muntean W; Leis HJ
    Thromb Haemost; 1995 Oct; 74(4):1163-8. PubMed ID: 8560429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous inactivation of thrombin and factor Xa by AT-III: influence of heparin.
    Odegård OR; Lie M
    Thromb Res; 1978 Apr; 12(4):697-700. PubMed ID: 663903
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of heparin on the extent of inhibition of thrombin by heparin cofactor.
    Owen WG
    Biochim Biophys Acta; 1977 Sep; 494(1):182-90. PubMed ID: 71165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of prothrombin activation by bothrojaracin, a C-type lectin from Bothrops jararaca venom.
    Monteiro RQ; Zingali RB
    Arch Biochem Biophys; 2000 Oct; 382(1):123-8. PubMed ID: 11051105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GAGs-potentiated inhibition of thrombin, factor Xa and plasmin in plasma and in a purified system containing antithrombin III - correlation with total charge density.
    Cofrancesco E; Vigo A; Pogliani EM
    Thromb Haemost; 1981 Dec; 46(4):749-51. PubMed ID: 6460339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.